FindTrial
Sign In

Gonadotropin-releasing hormone agonist

DRUG4 trials

Sponsors

RenJi Hospital, Kuban State Medical University, Shengjing Hospital, Helwan University

Conditions

Breast CancerChemotherapyGonadotropin Releasing Hormone AgonistsInfertilityInflammatory Breast CancerInvasive Ductal Breast CancerMucinous Breast CancerOvarian Function

Phase 2

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
Active, not recruitingNCT02221999
RenJi HospitalInflammatory Breast Cancer, Invasive Ductal Breast Cancer, Mucinous Breast Cancer +1
Start: 2013-09-30End: 2029-01-31Target: 250Updated: 2023-08-29
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
NCT05143723
Kuban State Medical UniversityInfertility
Start: 2020-01-20End: 2022-06-10Updated: 2021-12-03
Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer
RecruitingNCT05638594
Shengjing HospitalBreast Cancer
Start: 2022-12-20End: 2027-12-10Target: 236Updated: 2023-03-20

Unknown Phase

Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
CompletedNCT07127315
Helwan UniversityBreast Cancer, Chemotherapy, Gonadotropin Releasing Hormone Agonists +2
Start: 2022-06-01End: 2024-07-01Updated: 2026-08-11

Related Papers

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer
MedComm2024-03-0111 citations
Strain ultrasonic elastography imaging features of locally advanced breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival
BMC Medical Imaging2023-12-217 citations
Abstract P2-12-02: Efficacy, safety and survival of neoadjuvant chemotherapy with different estrogen deprivation stratified by menstrual status versus chemotherapy alone in locally advanced breast cancer (SHPD002)—— A randomized multicentre, open-label, phase 3 Triab
Cancer Research2022-02-151 citations
The Predictive Value of Pre-therapeutic Serum Gamma-glutamyl transferase in Efficacy and Adverse Reactions to Neoadjuvant Chemotherapy among Breast Cancer Patients
Journal of Breast Cancer2020-01-0111 citations
Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
2019-09-0527 citations
Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy.
2019-03-2910 citations